PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells
Overview
Neurology
Authors
Affiliations
Background: Mitochondrial dysfunction, bioenergetic deficit, and extensive oxidative stress underlie neuronal perturbation during the early stage of Alzheimer's disease (AD). Previously, we demonstrated that decreased PTEN-induced putative kinase 1 (PINK1) expression is associated with AD pathology in AD-affected human brains and AD mice.
Objective: In the present study, we highlight the essential role of PINK1 in AD-relevant mitochondrial perturbation and neuronal malfunction.
Methods: Using trans-mitochondrial "cybrid" (cytoplasmic hybrid) neuronal cells, whose mitochondria are transferred from platelets of patients with sporadic AD, we observed the effect of PINK1 in neuronal-like differentiation and synaptogenesis and mitochondrial functions.
Results: In AD cybrid cells, the downregulation of PINK1 is correlated to the alterations in mitochondrial morphology and function and deficit in neuronal-like differentiation. Restoring/increasing PINK1 by lentivirus transduction of PINK1 robustly attenuates mitochondrial defects and rescues neurite-like outgrowth. Importantly, defective PINK1 kinase activity fails to reverse these detrimental effects. Mechanistically, AD cybrid cells reveal a significant decrease in PINK1-dependent phosphorylated mitofusin (Mfn) 2, a key mitochondrial membrane protein that participates in mitochondrial fusion, and an insufficient autophagic activity for the clearance of dysfunctional mitochondria. Overexpression of PINK1, but not mutant PINK1 elevates phosphorylation of Mfn2 and autophagy signaling LC3-II. Accordingly, PINK1-overexpressed AD cybrids exhibit increases in mitochondrial length and density and suppressed reactive oxygen species. These results imply that activation of PINK1 protects against AD-affected mitochondrial dysfunction and impairment in neuronal maturation and differentiation.
Conclusion: PINK1-mediated mitophagy is important for maintaining mitochondrial health by clearance of dysfunctional mitochondria and therefore, improves energy homeostasis in AD.
Mitochondrial dysfunction and Alzheimer's disease: pathogenesis of mitochondrial transfer.
Wei Y, Du X, Guo H, Han J, Liu M Front Aging Neurosci. 2025; 16:1517965.
PMID: 39741520 PMC: 11685155. DOI: 10.3389/fnagi.2024.1517965.
O-GlcNAc impacts mitophagy via the PINK1-dependent pathway.
Alghusen I, Carman M, Wilkins H, Strope T, Gimore C, Fedosyuk H Front Aging Neurosci. 2024; 16:1387931.
PMID: 39175808 PMC: 11339348. DOI: 10.3389/fnagi.2024.1387931.
Mitochondria in Alzheimer's Disease Pathogenesis.
Reiss A, Gulkarov S, Jacob B, Srivastava A, Pinkhasov A, Gomolin I Life (Basel). 2024; 14(2).
PMID: 38398707 PMC: 10890468. DOI: 10.3390/life14020196.
Wang D, Zheng J, Sun X, Xie L, Yang Y Metabolites. 2024; 14(1).
PMID: 38276291 PMC: 10820555. DOI: 10.3390/metabo14010001.
New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease.
Samanta S, Akhter F, Roy A, Chen D, Turner B, Wang Y Brain. 2023; 147(5):1710-1725.
PMID: 38146639 PMC: 11484516. DOI: 10.1093/brain/awad432.